Evidence map›Paper›PMID 32047970›Full record

ArticleSocial psychiatry and psychiatric epidemiology2020

Association of response rate and prevalence estimates of common mental disorders across 129 areas in a nationally representative survey of adults in Japan.

Norito Kawakami, Naonori Yasuma, Kazuhiro Watanabe, Hanako Ishikawa, Hisateru Tachimori, Tadashi Takeshima, Maki Umeda, Haruki Shimoda, Daisuke Nishi

Abstract read
PubMed Publisher
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students.International journal of environmental research and public health · 2022
    Article
  4. Observational
  5. Article
  6. Article
  7. Anxiety and Depression Symptoms and Suicidal Ideation in Japan Rugby Top League Players.International journal of environmental research and public health · 2021
    Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Norito KawakamiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan. nkawakami@m.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-1080-2720
Naonori YasumaDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
Kazuhiro WatanabeDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
Hanako IshikawaDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
Hisateru TachimoriNational Center of Neurology and Psychiatry, Kodaira, Japan.
Tadashi TakeshimaNational Center of Neurology and Psychiatry, Kodaira, Japan.
Maki UmedaResearch Institute of Nursing Care for People and Community, University of Hyogo, Akashi, Japan.
Haruki ShimodaDepartment of Hygiene and Preventive Medicine, School of Medicine, Iwate Medical University, Yahaba, Japan.
Daisuke NishiDepartment of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
The University of Tokyo · JPNational Center of Neurology and Psychiatry · JPIwate Medical University · JPUniversity of Hyogo · JP

Funding

Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare H25-SEISHIN-IPPAN006Research and Development Grants for Comprehensive Research for Persons with Disabilities from the Japan Agency for Medical Research and Development 15dk0310020h0003
6 · The paper itself

Abstract

objectiveTo investigate the association of area response rate with prevalence estimates of mental disorders in the 2nd World Mental Health Survey (WMHJ2).

methodsThe sample of the WMHJ2 was selected from community residents in 129 areas from three regions of Japan. The surveys were conducted between 2013 and 2015, and 2450 (43.4%) responded. Mental disorders as well as three disorder classes (mood, anxiety, and substance use disorders) were identified using the WHO CIDI/DSM-IV. Response rates and 12-month and lifetime prevalences were calculated for each area. A generalized linear mixed model analysis was conducted to associate area response rate with the prevalence of mental disorders, controlling for sex, age, urbanity, and geographical region.

resultsArea response rates ranged from 0.05 to 0.80 across the 129 areas. Area response rate was not significantly associated with 12-month or lifetime prevalence of mental disorder. Lifetime prevalences of substance use disorder were significantly lower in a survey with a higher response rate than a survey of the same area with a lower response rate.

conclusionResponse rate may not strongly affect the prevalence estimates of mental disorders in a community-based survey of the prevalence of common mental disorders during a particular time frame. However, a lower response rate could be associated with overestimation of lifetime prevalence of substance use disorder. This needs further elucidation.

Indexed as

Mental DisordersAdultCross-Sectional StudiesDiagnostic and Statistical Manual of Mental DisordersHealth SurveysHumansJapanPrevalenceSurveys and QuestionnairesCross-sectional studyHierarchical modelLifetime prevalenceNon-responseSubstance use disorder

Identifiers

PMID32047970
OpenAlexW3004988590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.